Benefits and risks
Testosterone therapy can have different potential benefits depending on the symptoms and underlying cause. The evidence is stronger for some outcomes than others, and the expected timeframe and potential downsides also vary.
The key benefits and considerations are:
-
Sexual desire: Testosterone therapy can significantly improve libido in men with confirmed low testosterone, with effects often noticeable within 3–6 weeks. It is less likely to help when relationship or psychological factors are the main cause.
-
Erectile function: The improvement in erectile function is usually more moderate and may take 3–12 months. Men with vascular or medication-related erectile dysfunction may need other treatments as well, such as a PDE5 inhibitor.
-
Anemia correction: Testosterone can improve anemia in men with low testosterone, with changes typically seen over 3–6 months. However, treatment can also increase red blood cell counts too much, leading to erythrocytosis.
-
Lean mass and fat loss: Testosterone can support increases in lean mass and reductions in body fat, particularly when combined with exercise and adequate protein. These changes generally develop over 3–6 months.
-
Bone density: Testosterone can increase bone mineral density, although this has not clearly translated into fewer fractures. Improvements in bone density may take 6–36 months.
-
Depressive symptoms: Some men may experience a modest improvement in depressive symptoms, particularly those with confirmed testosterone deficiency and milder symptoms. Testosterone should not replace appropriate psychiatric treatment.
-
Vitality and general fatigue: Current evidence does not show a reliable benefit for general vitality or unexplained fatigue. Treating low testosterone without identifying the underlying cause of fatigue may delay the right diagnosis.
Overall, the potential benefits of testosterone therapy depend heavily on the symptoms, testosterone levels, and underlying cause. No single benefit should be considered in isolation; the potential improvement needs to be weighed against the individual risks and circumstances.
Side effects and fertility
Erythrocytosis is the most reproducible adverse effect. In TRAVERSE it occurred in 17.0% versus 3.3% of placebo recipients. The AUA advises that a hematocrit at or above 54% warrants intervention through dose reduction, temporary discontinuation, or phlebotomy, and that a baseline reading above 50% should prompt investigation before you start.
TRAVERSE also flagged atrial fibrillation at 3.5% versus 2.4% and acute kidney injury at 2.3% versus 1.5%, with pulmonary embolism at 0.9% versus 0.5%. Beyond those, acne, fluid retention, breast tenderness, and worsening sleep apnea show up in practice, and formulation matters. Gels transfer to partners and children through skin contact, and injections produce peaks and troughs that some men feel as mood swings.
Then there's fertility, which gets discussed too late far too often. Exogenous testosterone shuts down the hormonal signal that drives sperm production, and it does this at replacement doses. Roughly 65% of normospermic men become azoospermic within four months.
Recovery happens, but on an unhelpful schedule. Sperm concentration returns to 20 million per mL in 67% of men within 6 months and 90% within 12 months after stopping, with a small group needing two years or medical help. If children are anywhere in your plans, bank sperm before the first dose or choose a different treatment path.
Monitoring and stopping
Baseline work should include the two confirmed morning testosterone measurements, hemoglobin and hematocrit, and prostate assessment appropriate to your age and risk. The Endocrine Society recommends aiming for the mid-normal range during treatment, with a standardized plan for symptoms, adverse effects, serum testosterone, hematocrit, and prostate cancer risk during the first year.
Recheck at three and six months, then annually once things are stable. Warning signs that call for a dose change or a pause include a climbing hematocrit, new or worsening snoring and daytime sleepiness, leg swelling, and a PSA rise that outpaces what age alone explains.
The stopping rule is the part most clinics leave out. The guideline authors wrote that "regular monitoring for therapeutic response and adverse effects, combined with discontinuing therapy in patients who do not experience clear improvement in symptoms, should increase the likelihood of benefit while limiting expense and potential harm." Normalized levels with unchanged symptoms after an adequate trial mean the diagnosis was incomplete. Chasing testosterone therapy benefits by pushing the dose higher converts a treatment failure into a risk exposure, and TRT results that exist only on paper aren't worth maintaining.
Alternatives to testosterone
Plenty of low readings are consequences. Opioids suppress the axis directly, as do glucocorticoids and some antipsychotics, so a medication review belongs early in the workup. Untreated obstructive sleep apnea and chronic sleep restriction both lower testosterone, and treating them addresses the fatigue that sent you looking in the first place.
Weight is the biggest reversible lever in functional hypogonadism. A meta-analysis of weight-loss studies found total testosterone rose by 2.87 nmol/L with low-calorie diets and by 8.73 nmol/L after bariatric surgery, with bigger gains in men who lost more weight. Resistance training adds muscle and improves insulin sensitivity regardless of what happens to the hormone number.
For men who need testosterone raised but want to protect fertility, two options exist that keep the pituitary signal intact:
-
Clomiphene citrate, which blocks estrogen feedback and drives the body's own production. A randomized trial in 282 hypogonadal men found it as effective as hCG at restoring testosterone over three months.
-
Human chorionic gonadotropin, given alone or alongside testosterone to maintain sperm production.
Both are off-label for this purpose and require specialist evaluation with semen analysis, so they belong in a urology or endocrinology conversation rather than a walk-in hormone clinic. Neither replaces testosterone therapy benefits in men with primary testicular failure, where the testes can't respond to a stronger signal.
Get properly evaluated
The difference between a treatment that helps and one that only costs you money is the workup behind it. TNT Wellness, a Charlotte-area functional health practice operating since 1993, provides hormone testing and the follow-up monitoring that guidelines require. Book a consultation before self-diagnosing from a single lab result or starting unmonitored therapy, and get a clear read on whether testosterone therapy benefits apply to your situation.